Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
EYA4 encodes a member of the eyes absent (EYA) family of proteins. Additionally we are shipping EYA4 Proteins (4) and many more products for this protein.
Showing 10 out of 62 products:
Human Polyclonal EYA4 Primary Antibody for EIA, FACS - ABIN952150
Miller, Lan, Hardiman, Wu, Kordich, Patmore, Hegde, Cripe, Cancelas, Collins, Ratner: Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. in Oncogene 2010
Human Polyclonal EYA4 Primary Antibody for ELISA, WB - ABIN185511
Schönberger, Wang, Shin, Kim, Depreux, Zhu, Zon, Pizard, Kim, Macrae, Mungall, Seidman, Seidman: Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. in Nature genetics 2005
results implicate Eya4/Six1 (show SIX1 Antibodies) regulates normal cardiac function via p27 (show CDKN1B Antibodies)/casein kinase-2alpha/histone deacetylase 2 (show HDAC2 Antibodies) and indicate that mutations within this transcriptional complex and signaling cascade lead to the development of cardiomyopathy.
constructs of the homologous region ( Eya1HR and Eya4HR) interact with Six1 (show SIX1 Antibodies) prey constructs, although no interaction with Dach1 (show DACH1 Antibodies) prey was demonstrable
Eya4(-/-) mice developed otitis media with effusion; anatomic studies revealed abnormal middle ear cavity and eustachian tube dysmorphology.
that Eyes absent 4 (EYA4), originally identified as a co-transcription factor, stimulates the expression of IFN-beta (show IFNB1 Antibodies) and CXCL10 (show CXCL10 Antibodies) in response to the undigested DNA of apoptotic cells
The identification of a novel EYA4 truncation mutation associated with DFNA10, rather than syndromic hearing loss, supports a previously reported genotype-phenotype correlation in this gene.
results implicate Eya4/Six1 (show SIX1 Antibodies) regulates normal cardiac function via p27 (show PAK2 Antibodies)/casein kinase-2alpha/histone deacetylase 2 (show HDAC2 Antibodies) and indicate that mutations within this transcriptional complex and signaling cascade lead to the development of cardiomyopathy.
In a Dutch family with c.464del EYA4 mutation, hearing impairment begins as a mid-frequency hearing impairment in childhood and develops into a high-frequency, moderate hearing impairment later in life.
Genetic variations in the EYA4, GRHL2 (show GRHL2 Antibodies) and DFNA5 (show DFNA5 Antibodies) genes and their interactions with occupational noise exposure may play an important role in the incidence of noise-induced hearing loss (NIHL).
analysis of an EYA4 mutation causing hearing loss in a Chinese DFNA family
A novel missense mutation c.1643C>G (p.T548R) in EYA4 may cause autosomal dominant non-syndromic hearing impairment.
EYA4 mutations are associated with autosomal dominant non-syndromic hearing loss.
Exome Sequencing Identifies a Mutation in EYA4 as a Novel Cause of Autosomal Dominant Non-Syndromic Hearing Loss
EYA4 methylation may be identified in stool samples.
Results provide molecular and clinical information in order to gain improved understanding of the pathogenesis of DFNA10 protein EYA4 mutations and the genotypephenotype correlations of DFNA10 hearing loss.
This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may act as a transcriptional activator through its protein phosphatase activity, and it may be important for eye development, and for continued function of the mature organ of Corti. Mutations in this gene are associated with postlingual, progressive, autosomal dominant hearing loss at the deafness, autosomal dominant nonsyndromic sensorineural 10 locus. Defects in this gene are also associated with dilated cardiomyopathy 1J. Three transcript variants encoding distinct isoforms have been identified for this gene.
eyes absent homolog 4
, dJ78N10.1 (eyes absent)
, eyes absent 4